Feifan Xie

Publication Activity (10 Years)

Years Active: 2020-2024
Publications (10 Years): 18

Top Topics

Pseudomonas Aeruginosa

Replacement Therapy

Top Venues

Antimicrobial agents and chemotherapy

British journal of clinical pharmacology

The British journal of surgery

Pharmaceutical research

This page only lists publications with an associated author ORCID identifier.

Publications

Jesse Demuytere, Charlotte Carlier, Tom Van Helden, Joke Belza, Frank Vanhaecke, Feifan Xie, An Vermeulen, Joseph Weerts, Jürgen Thomale, Hannelore Denys, Philippe Tummers, Olivier Van Kerschaver, Wouter Willaert, Sarah Cosyns, Peter Merseburger, Arne Claeys, Jimmy Van den Eynden, Wim P Ceelen
Effects of hyperthermia on cisplatin tissue penetration and gene expression in peritoneal metastases: results from a randomized trial in ovarian cancer. The British journal of surgery 111 (4) (2024)
Jesse Demuytere, Charlotte Carlier, Tom Van Helden, Joke Belza, Frank Vanhaecke, Feifan Xie, An Vermeulen, Joseph Weerts, Jürgen Thomale, Hannelore Denys, Philippe Tummers, Olivier Van Kerschaver, Wouter Willaert, Sarah Cosyns, Peter Merseburger, Arne Claeys, Jimmy Van den Eynden, Wim P Ceelen
Effects of hyperthermia on cisplatin tissue penetration and gene expression in peritoneal metastases: results from a randomized trial in ovarian cancer. The British journal of surgery 111 (4) (2024)
Xiaonan Zhang, Yan Wang, Sanwang Li, Feifan Xie, Hanxi Yi
Simulated drug disposition in critically ill patients to evaluate effective PK/PD targets for combating Pseudomonas aeruginosa resistance to meropenem. Antimicrobial agents and chemotherapy 68 (3) (2024)
Yunan Yan, Qiushi Wang, Wei Wu, Hanxi Yi, Feifan Xie
Evaluation of Various Approaches to Estimate Transplacental Clearance of Vancomycin for Predicting Fetal Concentrations using a Maternal-Fetal Physiologically Based Pharmacokinetic Model. Pharmaceutical research 41 (5) (2024)
Xiaonan Zhang, Yan Wang, Sanwang Li, Feifan Xie, Hanxi Yi
Simulated drug disposition in critically ill patients to evaluate effective PK/PD targets for combating Pseudomonas aeruginosa resistance to meropenem. Antimicrobial agents and chemotherapy 68 (3) (2024)
Xiaonan Zhang, Yan Wang, Sanwang Li, Feifan Xie, Hanxi Yi
Simulated drug disposition in critically ill patients to evaluate effective PK/PD targets for combating Pseudomonas aeruginosa resistance to meropenem. Antimicrobial agents and chemotherapy (2024)
Xiaonan Zhang, Yan Wang, Sanwang Li, Feifan Xie, Hanxi Yi
Simulated drug disposition in critically ill patients to evaluate effective PK/PD targets for combating Pseudomonas aeruginosa resistance to meropenem. Antimicrobial agents and chemotherapy 68 (3) (2024)
Xiaonan Zhang, Yan Wang, Sanwang Li, Feifan Xie, Hanxi Yi
Simulated drug disposition in critically ill patients to evaluate effective PK/PD targets for combating Pseudomonas aeruginosa resistance to meropenem. Antimicrobial agents and chemotherapy 68 (3) (2024)
Xiaonan Zhang, Yan Wang, Sanwang Li, Feifan Xie, Hanxi Yi
Simulated drug disposition in critically ill patients to evaluate effective PK/PD targets for combating Pseudomonas aeruginosa resistance to meropenem. Antimicrobial agents and chemotherapy 68 (3) (2024)
Yunan Yan, Qiushi Wang, Wei Wu, Hanxi Yi, Feifan Xie
Evaluation of Various Approaches to Estimate Transplacental Clearance of Vancomycin for Predicting Fetal Concentrations using a Maternal-Fetal Physiologically Based Pharmacokinetic Model. Pharmaceutical research (2024)
Xiaonan Zhang, Yan Wang, Sanwang Li, Feifan Xie, Hanxi Yi
Simulated drug disposition in critically ill patients to evaluate effective PK/PD targets for combating Pseudomonas aeruginosa resistance to meropenem. Antimicrobial agents and chemotherapy 68 (3) (2024)
Qiushi Wang, Yunan Yan, Sanwang Li, Hanxi Yi, Feifan Xie
Physiologically based pharmacokinetic modelling of cefoperazone in paediatrics. British journal of clinical pharmacology (2024)
Sanwang Li, Sucui Zhu, Feifan Xie
Population pharmacokinetic/pharmacodynamic evaluations of amikacin dosing in critically ill patients undergoing continuous venovenous hemodiafiltration. The Journal of pharmacy and pharmacology (2023)
Yaru Peng, Iris K Minichmayr, Han Liu, Feifan Xie, Lena E Friberg
Multistate modeling for survival analysis in critically ill patients treated with meropenem. CPT: pharmacometrics & systems pharmacology (2023)
Qiufen Yin, Zeneng Cheng, Minghua Yang, Shengfeng Wang, Feifan Xie
A semi-mechanistic pharmacokinetic/pharmacodynamic model for alanine aminotransferase-based hepatotoxicity of methotrexate in paediatric patients with acute lymphoid leukemia. British journal of clinical pharmacology (2023)
Sanwang Li, Feifan Xie
Foetal and neonatal exposure prediction and dosing evaluation for ampicillin using a physiologically-based pharmacokinetic modelling approach. British journal of clinical pharmacology (2022)
Yaru Peng, Zeneng Cheng, Feifan Xie
Population Pharmacokinetic Meta-Analysis and Dosing Recommendation for Meropenem in Critically Ill Patients Receiving Continuous Renal Replacement Therapy. Antimicrobial agents and chemotherapy 66 (9) (2022)
Feifan Xie, Jan Van Bocxlaer, An Vermeulen
Physiologically based pharmacokinetic modelling of lisinopril in children: A case story of angiotensin converting enzyme inhibitors. British journal of clinical pharmacology 87 (3) (2020)